Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMRE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,987
Award facts
- Contract value 100% obligated
- $47,987.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $47,987 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order was issued without a set-aside designation and carries an ultimate completion date of January 22, 2026. DMS Pharmaceutical Group is positioned as a critical supplier within the Department of Defense's pharmaceutical supply chain, distributing a comprehensive range of products including branded and generic prescription medications, biologics, vaccines, and medical consumables to support military healthcare operations.
This delivery order operates under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent IDC, awarded on November 13, 2025, carries a $500 million ceiling value and runs through December 31, 2036, positioning the company as one of multiple regional prime vendor contractors within the $30.3 billion PPV-G GEN V acquisition strategy. The delivery order structure enables DLA to procure firm fixed-price pharmaceutical products and medical consumables as needed to support recurring medical supply requirements across Department of Defense healthcare facilities worldwide, leveraging DMS Pharmaceutical Group's established performance and diverse product portfolio.
Quick answers
Who was awarded contract SPE2DU26FEMRE?
SPE2DU26FEMRE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DU26FEMRE worth?
The government has obligated $47,987 on SPE2DU26FEMRE.
Is contract SPE2DU26FEMRE an order under another contract?
Yes. SPE2DU26FEMRE is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMRE competed?
The extent of competition for SPE2DU26FEMRE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award